Exemestane seems to stimulate tumour growth in men with prostate carcinoma

被引：4
作者：
Bonomo, M
Mingrone, W
Brauchli, P
Hering, F
Goldhirsch, A
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2003年 / 39卷 / 14期
关键词：
D O I：
10.1016/S0959-8049(03)00486-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2111 / 2112
页数：2
相关论文
共 15 条
[1]   Antiandrogen withdrawal in the treatment of hormone-relapsed prostate cancer: Single institutional experience [J].
Caldiroli, M ;
Cova, V ;
Lovisolo, JA ;
Reali, L ;
Bono, AV .
EUROPEAN UROLOGY, 2001, 39 :6-9
[2]  
Castagnetta LAM, 1997, J STEROID BIOCHEM, V61, P287
[3]   AROMATASE INHIBITION - 4-HYDROXYANDROSTENEDIONE (4-OHA, CGP-32349) IN ADVANCED PROSTATIC-CANCER [J].
DAVIES, JH ;
DOWSETT, M ;
JACOBS, S ;
COOMBES, RC ;
HEDLEY, A ;
SHEARER, RJ .
BRITISH JOURNAL OF CANCER, 1992, 66 (01) :139-142
[4]  
Hiramatsu M, 1997, PROSTATE, V31, P118
[5]  
Huggins C, 1941, CANCER RES, V1, P293
[6]   Studies on prostate cancer II The effects of castration on advanced carcinoma of the prostate gland [J].
Huggins, C ;
Stevens, RE ;
Hodges, CV .
ARCHIVES OF SURGERY, 1941, 43 (02) :209-223
[7]   Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer [J].
Kelly, WK .
EUROPEAN UROLOGY, 1998, 34 :18-23
[8]  
Negri-Cesi P, 1999, PROSTATE, V41, P224, DOI 10.1002/(SICI)1097-0045(19991201)41:4<224::AID-PROS2>3.0.CO
[9]  
2-Q
[10]  
Santen RJ, 2001, CANCER, V92, P2095, DOI 10.1002/1097-0142(20011015)92:8<2095::AID-CNCR1550>3.0.CO
12